Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
British Journal of Haematology|June 2, 2007
Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemiaClaire Seedhouse, Nigel Russell
Frontiers in Oncology|December 2, 2020
UK Experience of an Alternative ATO Dosing Regimen in APLNigel Russell, Richard Dillon
Clinical Lymphoma, Myeloma & Leukemia|April 12, 2026
SOHO State of the Art Updates and Next Questions: Is Favorable-risk AML Always Favorable?Aditya Tedjaseputra, Nigel Russell, Richard Dillon
Clinical Lymphoma, Myeloma & Leukemia|May 11, 2024
SOHO State of the Art Updates and Next Questions: Pre-emptive Therapy at Molecular Measurable Residual Disease Failure in Acute Myeloid LeukemiaAditya Tedjaseputra, Nigel Russell, Richard Dillon
Acta Haematologica|September 17, 2005
Future directions in haematology: beyond multiple myelomaH Grant Prentice, Stephano Sacchi, Nigel Russell
Acta Haematologica|November 26, 2023
Optimal Post-Remission Consolidation Therapy in Patients with AMLCarlos Jimenez-Chillon, Richard Dillon, Nigel Russell
Leukemia Research|June 14, 2003
Flow cytometric measurement of phosphorylated STAT5 in AML: lack of specific association with FLT3 internal tandem duplicationsMonica Pallis, Claire Seedhouse, Martin Grundy, et al.
Leukemia & Lymphoma|February 13, 2018
Quantitative assessment of the sensitivity of dormant AML cells to the BAD mimetics ABT-199 and ABT-737Ning Yu, Claire Seedhouse, Nigel Russell, et al.
Pageof 12